Thanks for the thoughtful reply, doc. I'm sure all of appreciate your perspective. I don't have a clue as to how physicians might perceive such a presentation. As always with GNBT and all of the other OTC stocks, they have to acquire the resources and then deliver.

That brings to mind another question. Are the proceeds of an NGIO IPO in a silo, or can Generex use them as needed.